Cancer Drugs Drive Nearly One-Fifth Of Pharma Sales The global pharmaceutical industry's revenue is increasingly concentrated in a handful of high-value drug classes , with oncology, diabetes/obesity treatments and immunology leading the charge. As Statista's Tristan Gaudiat details below, according to estimates from Statista Market Insights , cancer drugs alone generated over $217 billion last ye...
Cancer Drugs Drive Nearly One-Fifth Of Pharma Sales The global pharmaceutical industry's revenue is increasingly concentrated in a handful of high-value drug classes , with oncology, diabetes/obesity treatments and immunology leading the charge. As Statista's Tristan Gaudiat details below, according to estimates from Statista Market Insights , cancer drugs alone generated over $217 billion last year, making oncology the largest therapeutic segment, driving nearly one-fifth (18 percent) of all pharmaceutical sales. You will find more infographics at Statista Antidiabetic medicines rank second, with estimated sales of over $85 billion in 2025, contributing 7 percent to global market revenues. Some of the top-grossing drugs include Merck's Keytruda, an immunotherapy for multiple cancers with almost $30 billion in revenue in 2024, as well as Eli Lilly's Mounjaro and Novo Nordisk's Ozempic/Wegovy, used for diabetes treatment and weight loss, and bringing in more than $10 billion annually for their parent companies. Tyler Durden Mon, 01/12/2026 - 04:15
In this article XOM CVX COP Follow your favorite stocks CREATE FREE ACCOUNT Darren Woods, chairman and chief executive officer Exxon Mobil Corp., during a meeting with oil executives in the East Room of the White House in Washington, DC, US, on Friday, Jan. 9, 2026. Bloomberg | Bloomberg | Getty Images U.S. President Donald Trump threatened to sideline Exxon Mobil from Venezuela's energy market, s...
In this article XOM CVX COP Follow your favorite stocks CREATE FREE ACCOUNT Darren Woods, chairman and chief executive officer Exxon Mobil Corp., during a meeting with oil executives in the East Room of the White House in Washington, DC, US, on Friday, Jan. 9, 2026. Bloomberg | Bloomberg | Getty Images U.S. President Donald Trump threatened to sideline Exxon Mobil from Venezuela's energy market, saying he didn't like their response to his calls for oil companies to quickly re-enter the South American country. "I didn't like Exxon's response. You know we have so many that want it. I'd probably be inclined to keep Exxon out," Trump told reporters on board Air Force One on Sunday. "They're playing too cute," he added. His comments come shortly after Exxon CEO Darren Woods made headlines for saying at a White House meeting with Trump that the Venezuelan market is " uninvestable " in its current state. An Exxon spokesperson did not immediately respond to a request for comment. Shares were 1% lower in premarket trade on Monday. Speaking alongside several other American oil executives on Friday, Woods said Exxon would need to see "some pretty significant changes" if it was to re-enter the country for a third time. Venezuela seized Exxon's and ConocoPhillips 's assets in 2007, and Caracas owes the companies billions of dollars in outstanding claims from arbitration cases. Read more What the Big Oil executives told Trump about investing in Venezuela Trump says oil companies will spend $100 billion in Venezuela with U.S. protection What Trump’s Venezuela intervention means for Guyana’s vast oil wealth Woods said the company would need to see changes to commercial frameworks, the legal system and hydrocarbon laws, alongside what he described as "durable" investment protections. "We're confident that with this administration and President Trump working hand‑in‑hand with the Venezuelan government that those changes can be put in place," Woods said. He added that Exxon was prepar...
(RTTNews) - Toy maker Mattel, Inc. announced the launch of its first-ever autistic Barbie doll, developed in partnership with The Autistic Self Advocacy Network or ASAN, a non-profit disability rights organization run by and for autistic individuals. The new doll is now available
(RTTNews) - Toy maker Mattel, Inc. announced the launch of its first-ever autistic Barbie doll, developed in partnership with The Autistic Self Advocacy Network or ASAN, a non-profit disability rights organization run by and for autistic individuals. The new doll is now available
If you have cash available to invest, the best time to get started always is "now" -- regardless of the time of year. That's because the earlier you begin, the more time you have to grow your portfolio. Investing isn't about jumping in and out of stocks; instead, it's about choosing excellent players, paying a reasonable price, and keeping them in your portfolio for a number of years. This long-te...
If you have cash available to invest, the best time to get started always is "now" -- regardless of the time of year. That's because the earlier you begin, the more time you have to grow your portfolio. Investing isn't about jumping in and out of stocks; instead, it's about choosing excellent players, paying a reasonable price, and keeping them in your portfolio for a number of years. This long-term investing strategy is more likely to score a win for you than if you try to quickly buy and then sell the day's hottest stocks -- and it's definitely less stressful. Investing doesn't require thousands of dollars or more -- you could get started with very little if you're buying lower-priced stocks or investing in fractional shares of some of the market's bigger players. You might buy a share or two and add to your investments when it's financially possible for you to do so. For the purposes of this article, I'll talk about where to deploy $10,000 at the start of this new year. But even with a much smaller amount, you can apply the same ideas and potentially score a win over the long term. Let's get started. Continue reading